文献速递慢病管理老年与多病共存

MULTIPAP研究:改善多病共存患者的医疗照护

MULTIPAP Study: Improving healthcare for patients with multimorbidity.
PubMed 文献 · Br J Gen Pract · 2020-01-01

MULTIPAP研究是一项在西班牙基层医疗开展的实用整群随机临床试验,评估基于Ariadne原则的以患者为中心的复杂干预对65-74岁多病共存且多重用药患者的效果。主要结局为6个月随访时药物适当性指数(MAI)的组间差异,结果显示干预组MAI显著改善,但生活质量等次要结局无显著差异。

要点

  • 干预包括全科医生电子培训与以患者为中心的访谈,可显著改善药物适当性。
  • 生活质量等次要结局在12个月随访时未见显著改善。

核心结论

  • 基于Ariadne原则的干预显著改善了多病共存且多重用药患者的药物适当性。
  • 观察到的生活质量改善无统计学意义。

研究设计与样本

  • 实用整群随机临床试验,在全科医疗环境中开展。
  • 全科医生随机分配至常规照护组或MULTIPAP干预组。
  • 纳入65-74岁多病共存且多重用药的患者。
  • 来自西班牙38个基层医疗中心的117名全科医生招募了593名患者。

关键数值与推荐

  • 主要结局为6个月随访时MAI的组间差异。
  • 次要结局包括12个月随访时的MAI、生活质量、患者感知、医疗服务使用、治疗依从性和成本效果。

临床怎么用

  • 全科医生可通过电子培训掌握多病共存、多重用药和共享决策的关键概念。
  • 采用以患者为中心的访谈可能改善药物适当性。
  • 该干预形式可行且被专业人员接受。

局限性

  • 次要结局如生活质量和医疗服务使用等未显示显著改善。
  • 未来研究需验证该培训形式是否便于实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The steady rise in multimorbidity entails serious consequences for our populations, challenges healthcare systems, and calls for specific clinical approaches of proven effectiveness. The MULTIPAP Study comprises three sequential projects (MULTIPAP and MULTIPAP Plus RCTs, and the MULTIPAP Cohort). Results of MULTIPAP RCT are presented. AIM: To evaluate the effectiveness of a complex, patient-centred intervention in young-old patients with multimorbidity and polypharmacy. METHOD: Pragmatic cluster-randomised clinical trial in a primary healthcare setting. GPs were randomly allocated to either conventional care or the MULTIPAP intervention based on the Ariadne Principles with two components: GPs e-training (that is, eMULTIPAP addresses specific, key concepts on multimorbidity, polypharmacy and shared decision-making) and GP-patient-centred interview. Young-old patients aged 65-74 years with multimorbidity and polypharmacy were included. MAIN OUTCOME: difference in the Medication Appropriateness Index (MAI) after 6-month follow-up between groups. SECONDARY OUTCOMES: MAI, quality of life, patient perception, health services use, treatment adherence and cost-effectiveness after 12-month follow-up. RESULTS: 117 GPs from 38 Spanish primary health care recruited 593 patients randomly assigned to the intervention/control groups. Difference in MAI scores between groups in the intention-to-treat analysis after 6 months' follow-up: -2.42 (-4.27 to -0.59), P = 0.009 (adjusted difference in mean MAI score -1.81(-3.35 to -0.27), P = 0.021). SECONDARY OUTCOMES: not significant, including quality of life (adjusted difference in mean EQ-5D-5L (VAS) 2.94 (-1.39 to 7.28), P = 0.183, EQ-5D-5L (index) -0.006(-0.034 to 0.022), P = 0.689). CONCLUSION: The intervention significantly improved medication appropriateness. The observed quality of life improvement was not significant. GPs e-training in multimorbidity has shown to be feasible and well accepted by the professionals. Future studies may test whether this format facilitates implementation.

来源:Br J Gen Pract,查看原文。版权归原作者所有。

引用

  1. Prados-Torres A, Cura-González ID, Prados-Torres JD, et al. MULTIPAP Study: Improving healthcare for patients with multimorbidity. Br J Gen Pract. 2020. PMID: 32554653. doi:10.3399/bjgp20X711257

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。